Systems pharmacology and drug repositioning- an integrated approach to metabolic diseases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Systems pharmacology and drug repositioning- an integrated approach to metabolic diseases ; volume:10 ; number:2 ; day:17 ; month:10 ; year:2012 ; pages:1 ; date:10.2012
Journal of translational medicine ; 10, Heft 2 (17.10.2012), 1, 10.2012
- Creator
-
Luther, Michael A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-S2-A18
- URN
-
urn:nbn:de:1111-2016041442579
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luther, Michael A.
- SpringerLink (Online service)
Other Objects (12)
Drug repositioning
Large-scale computational drug repositioning to find treatments for rare diseases
Drug repositioning using drug-disease vectors based on an integrated network
Metabolic flexibility in inherited metabolic diseases
Enriching limited information on rare diseases from heterogeneous networks for drug repositioning
Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs)
Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning
Transcriptome-Guided Drug Repositioning
In silico drug repositioning based on integrated drug targets and canonical correlation analysis
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties
Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases
Peptide-based multi-agonists: a new paradigm in metabolic pharmacology
Drug repositioning
Large-scale computational drug repositioning to find treatments for rare diseases
Drug repositioning using drug-disease vectors based on an integrated network
Metabolic flexibility in inherited metabolic diseases
Enriching limited information on rare diseases from heterogeneous networks for drug repositioning
Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs)
Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning
Transcriptome-Guided Drug Repositioning
In silico drug repositioning based on integrated drug targets and canonical correlation analysis
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties
Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases
Peptide-based multi-agonists: a new paradigm in metabolic pharmacology
Drug repositioning
Large-scale computational drug repositioning to find treatments for rare diseases
Drug repositioning using drug-disease vectors based on an integrated network
Metabolic flexibility in inherited metabolic diseases
Enriching limited information on rare diseases from heterogeneous networks for drug repositioning
Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs)
Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning
Transcriptome-Guided Drug Repositioning
In silico drug repositioning based on integrated drug targets and canonical correlation analysis
Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties
Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases